Concepedia

Hans Minderman

HM

59

Publications

4.9K

Citations

37

H-Index

1989

Active since

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

University at Buffalo, State University of New York

Radboud University Nijmegen

National Institutes of Health

University of Pennsylvania

Hans Minderman is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

1989–2023

59

Publications

59

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch et al. · European Journal of Immunology · 2019 · 965 citations · Full text

, , +18

Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720

Maria R. Baer, Stephen L. George, Richard K. Dodge et al. · Blood · 2002 · 365 citations · Full text

Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator

Misbah Qadir, Kieran L. O’Loughlin, Stacy M. Fricke et al. · Clinical Cancer Research · 2005 · 237 citations · Full text

Peroxiredoxin 1 Stimulates Secretion of Proinflammatory Cytokines by Binding to TLR4

Jonah Riddell, Xiangyang Wang, Hans Minderman et al. · The Journal of Immunology · 2009 · 205 citations · Full text

Purity and yield of melanoma exosomes are dependent on isolation method

Shin La Shu, Yunchen Yang, Cheryl Allen et al. · Journal of Extracellular Vesicles · 2019 · 181 citations · Full text

, , +20

Rows per page

1–5 of 59